Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots

Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes ...

Boston Scientific to buy Penumbra for more than $14 billion

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...

Penumbra stock jumps. It’s being bought by Boston Scientific for $14.5 billion

Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst ...

Boston Scientific to buy Penumbra in $14.5 billion deal

Boston Scientific said ​on Thursday ‌it will buy Penumbra ‌in a deal valued at about $14.5 billion to ⁠expand ‌its vascular ...
MedTech Dive

Boston Scientific to acquire Penumbra for $14.5B

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.
Fierce Biotech

Thermo Fisher Scientific teams up with Nvidia, TetraScience for next-gen AI workflow projects

Thermo Fisher Scientific is starting 2026's J.P. Morgan Healthcare Conference with a bang, announcing two new deals with an ...

AI tools are expanding individual capabilities while contracting scientific attention, research finds

Artificial intelligence promises to accelerate scientific discovery and open new frontiers of inquiry. But new research from ...

Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The ...